VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 17 filers reported holding VANECK VECTORS ETF TR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,907,603 | -11.0% | 70,888 | -0.4% | 1.74% | -7.3% |
| Q2 2023 | $2,142,710 | -22.9% | 71,163 | -17.2% | 1.87% | -22.2% |
| Q1 2023 | $2,780,183 | +104496.8% | 85,941 | -7.3% | 2.41% | +2.2% |
| Q4 2022 | $2,658 | -99.9% | 92,749 | -0.1% | 2.36% | +19.4% |
| Q3 2022 | $2,239,000 | -7.5% | 92,823 | +5.0% | 1.97% | -2.6% |
| Q2 2022 | $2,421,000 | -28.1% | 88,435 | +0.7% | 2.03% | -20.0% |
| Q1 2022 | $3,367,000 | +10.1% | 87,801 | -8.0% | 2.53% | +11.8% |
| Q4 2021 | $3,058,000 | +2.2% | 95,486 | -6.0% | 2.27% | +0.8% |
| Q3 2021 | $2,993,000 | -12.8% | 101,555 | +0.5% | 2.25% | -10.1% |
| Q2 2021 | $3,432,000 | – | 101,003 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |